Hutchinson Institute for Cancer Outcomes Research


HICOR Model graphic

HICOR is a research institute at Fred Hutch whose mission is to improve cancer prevention, detection and treatment in ways that will reduce the economic and human burden of cancer—ultimately leading to better outcomes for patients.

To achieve this, HICOR is bringing together patient organizations, clinicians, industry leaders, insurers and policy developers to share cancer-related data and generate performance metrics that are clinically relevant and can guide improvements in cancer care.  

With our world-class expertise in cancer research, diagnosis, and treatment, we are uniquely positioned to act as a trusted resource and a facilitator of collaboration to improve value in cancer care. 

HICOR Solutions

The cost and quality of cancer treatment vary greatly across our healthcare systems and geographic regions in the United States. Higher spending does not always translate into better outcomes. We need to reduce spending on interventions that don’t work and invest in those that do.

HICOR is taking a multi-faceted approach to promoting consistency, cost-effectiveness and better outcomes:

HICOR IQ. We are integrating cancer treatment, cost and outcomes data from cancer registries, electronic medical records, insurance claims and patient-reported information to identify trends and the most effective approaches.

Tools for decision-makers. We are leading efforts to adapt value of information and research methods to prioritize future research with the greatest potential impact into tools for national decision makers.

Value in Cancer Care. We are leading a consensus-based initiative that brings together regional stakeholders in cancer care and research to define value measures and test novel models of care and financing.   

Research and Development.  HICOR investigator, Lotte Steuten, has developed methods to help innovators identify which new cancer-related technologies are likely to be cost-effective and yield the highest return on investment.



  • Cancer incidence in the United States is projected to reach 1.9 million in 2020 - more than a 20 percent increase from 2010.
  • Cancer care in the United States is projected to cost nearly $175 billion a year by 2020 - a 40 percent increase from 2010.
  • Cancer patients are bearing an increasing share of the cost of treatment and are two-and-a-half times more likely to declare bankruptcy than those without cancer.